
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
FierceBiotech's John Carroll discusses his personal experience with the ongoing fallout over Turing Pharmaceuticals' drug pricing and CEO Martin Shkreli's public response.
Continue listening to more episodes from FierceBiotech Radio.

May 15, 2018 - 15:46
FierceBiotech chats with a pair of lawyers about how drug pricing is unique in the U.S. and how the bioph...

Mar 13, 2018 - 21:26
Fierce editors discuss the 2018 FierceMadness drug name tournament, its origins, and our favorites headin...

Oct 31, 2017 - 09:46
FierceBiotech Radio rose from the grave for this special Halloween episode where we sat down with some of...

Mar 18, 2016 - 28:41
Fierce editors discuss the pending retirement of GlaxoSmithKline CEO Andrew Witty, Eli Lilly's bold decis...

Feb 26, 2016 - 41:26
Fierce editors discuss the confirmation of Robert Califf as the next FDA commissioner, Sanofi's efforts t...

Feb 18, 2016 - 39:23
Fierce editors discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, an...

Feb 11, 2016 - 40:30
Fierce editors discuss a bizarre congressional hearing, how biotech's slump affects the buyout climate, a...

Feb 4, 2016 - 36:41
Fierce editors discuss the future of Gilead Sciences, biotech's continued slump on Wall Street, and the l...